Status:

APPROVED_FOR_MARKETING

Pre-approval Access Single Patient Request for Niraparib / Abiraterone Acetate Combination (Nira/AA Combination)

Lead Sponsor:

Janssen Research & Development, LLC

Conditions:

Metastatic Castration-resistant Prostate Cancer

Eligibility:

MALE

18+ years

Brief Summary

The purpose of this pre-approval access is to provide Niraparib plus Abiraterone Acetate (Nira/AA combination) in the treatment of (a) participant(s) with first line metastatic castration-resistant pr...

Eligibility Criteria

Inclusion

  • Diagnosed with metastatic castration-resistant prostate cancer (mCRPC)
  • A confirmed homologous recombination repair (HRR) gene alteration as identified by a genomic assay through use of a validated test
  • Eastern Cooperative Oncology Group Performance Score (ECOG PS) Grade of 0 or 1
  • Willing to receive concomitant prednisone/ prednisolone 10 milligrams (mg) (not provided by Janssen) daily while receiving niraparib/abiraterone acetate (Nira/AA) combination treatment
  • Willing to continue treatment with gonadotropin-releasing hormone (GnRH) analogue if not surgically castrated

Exclusion

  • Prior treatment with a Poly ADP-ribose Polymerase (PARP) inhibitor
  • Prior systemic therapy for mCRPC (that is, taxane-based chemotherapy, androgen signaling inhibitors). Ongoing androgen deprivation therapy (ADT), prior systemic treatment (example, apalutamide, enzalutamide, darolutamide, docetaxel) for earlier disease settings (example, hormone sensitive disease, non-metastatic castration-resistant disease); and treatment recently initiated with abiraterone acetate for mCRPC less than or equal to (\<=) 60 days is permitted
  • Other treatment options available or participant eligible or able to participate in a clinical trial for first line mCRPC with HRR gene alterations
  • Moderate-severe pain
  • History or current diagnosis of myelodysplastic syndrome (MDS)/acute myeloid leukemia (AML)

Key Trial Info

Start Date :

Trial Type :

EXPANDED_ACCESS

End Date :

Estimated Enrollment :

Patients enrolled

Trial Details

Trial ID

NCT05401214

Last Update

June 13 2025

Active Locations (0)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 0 (0 locations)

No Results Found

We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.

Pre-approval Access Single Patient Request for Niraparib / Abiraterone Acetate Combination (Nira/AA Combination) | DecenTrialz